(Q37209889)

19 August 2017

Adalimumab for the treatment of fistulas in patients with Crohn's disease (English)

1 reference

19 August 2017

0 references

0 references

0 references

William Jeffery Sandborn

3

object named as

W J Sandborn

1 reference

19 August 2017

6

P Rutgeerts

1 reference

19 August 2017

Jean-Frédéric Colombel

1

object named as

J-F Colombel

1 reference

19 August 2017

5

G D'Haens

1 reference

19 August 2017

D A Schwartz

2

1 reference

19 August 2017

M A Kamm

4

1 reference

19 August 2017

R Enns

7

1 reference

19 August 2017

R Panaccione

8

1 reference

19 August 2017

S Schreiber

9

1 reference

19 August 2017

J Li

10

1 reference

19 August 2017

J D Kent

11

1 reference

19 August 2017

K G Lomax

12

1 reference

19 August 2017

P F Pollack

13

1 reference

19 August 2017

language of work or name

English

0 references

publication date

6 February 2009

1 reference

19 August 2017

1 reference

19 August 2017

58

1 reference

19 August 2017

7

1 reference

19 August 2017

940-948

1 reference

Certolizumab pegol for the treatment of Crohn's disease

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689393

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689393

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689393

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689393

Infliximab maintenance therapy for fistulizing Crohn's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689393

Crohn's fistula: current concepts in management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689393

Diagnosis and treatment of perianal fistulas in Crohn disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689393

Infliximab for the treatment of fistulas in patients with Crohn's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689393

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689393

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689393

The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota

3 September 2018

1 reference

12 December 2020

An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease

1 reference

12 December 2020

Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients

1 reference

12 December 2020

Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study

1 reference

12 December 2020

Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial

1 reference

12 December 2020

Maintenance therapy with certolizumab pegol for Crohn's disease

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.2008.159251

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19201775

1 reference